Current pharmacotherapy of hepatitis C infections

Abstract

Proper analysis of the current treatment strategies available for hepatitis C, including already established antiviral therapies and emerging innovative approaches aimed at achieving better clinical outcomes. Furthermore, it will explore the global efforts in developing preventive methods, highlighting both the successes and limitations of public health initiatives aimed at reducing the transmission of HCV.